Japan’s CBD Industry Recieves First Investments From Publicly Listed Companies Following
AstraSana Japan Co., Ltd. has formed a capital and business alliance with Japan’s GSI Creos Corporation, bolstered by their investment. This partnership will enhance the wholesale distribution of CBD raw materials across Japan, leveraging the strengths of both companies.
Through this alliance, the AstraSana Group, headquartered in Switzerland, will establish a robust supply chain to deliver Swiss-made, high-quality CBD raw materials across Japan, with a mission is to ensure customers receive safe, reliable products of the highest standard.
Through this alliance, AstraSana Group (headquartered in Switzerland) will establish a stable supply chain to deliver Swiss-made, high-quality CBD raw materials nationwide in Japan. We aim to provide safe and reliable products to our customers.
By leveraging GSI Creos’ extensive resources and networks, AstraSana says it will offer even higher-quality services to customers. Based on this robust partnership, it will actively contribute to the growth and development of the CBD market through various approaches.
“At AstraSana Japan, we prioritize safety through third-party analyses, ensure the delivery of superior-quality products, and place customer trust and satisfaction at the heart of everything we do. We are dedicated to enhancing customers’ ‘Quality of Life’ (QOL) while staying at the forefront of technological innovation.
The Potential of CBD in the Japanese Market
CBD (Cannabidiol), a hemp-derived compound, is legally recognized as a safe material in Japan. With global demand on the rise, the opportunities for CBD in the Japanese market are rapidly expanding. This collaboration strengthens AstraSana’s supply chain, addressing past challenges, and further promotes the availability of safe and reliable CBD products across the country.
About GSI Creos Corporation
Website: Home | GSI Creos Corporation GSI Creos is an innovative trading company with nine domestic and 24 international bases. Operating globally in both “textiles” and “industrial products,” their business spans a diverse range, including textile raw materials, apparel, chemicals, hobby materials, machinery, semiconductor components, and nanotechnology. Guided by the purpose, “Creating quality of life for the next generation,” GSI Creos champions ESG management to tackle social challenges and promote human well-being.
About AstraSana Group / AstraSana Holding AG
Website: AstraSana Holding AG The AstraSana Group is a leading global company specializing in cannabinoid raw materials and medical cannabis. Headquartered in Zurich, Switzerland, AstraSana Holding AG operates through affiliates in the Czech Republic, the UK, and Japan. Collaborating with partners across Europe and South America, including Belgium, the group continues to expand its worldwide presence.
Yves Antoniazzi
Nyckelord
As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.
Följ news aktuell GmbH
Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.
Senaste pressmeddelandena från news aktuell GmbH
Canary Islands, first European destination in ROBLOX17.1.2025 13:00:00 CET | Press Release
Turismo de Canarias presents Find the Seasouls, an interactive experience within ROBLOX designed to promote environmental care in new generations, calling for respect for natural parks, protected spaces and the biodiversity of the islands
Effective immediately: French purchasing group Francap starts pooling procurement of their strong private label brands under the international umbrella of the EMD Alliance17.1.2025 12:00:00 CET | Pressmeddelande
Pfäffikon/Switzerland, 17/01/2025: Right at the start of 2025, the European Marketing Distribution (EMD) network is once again demonstrating the additional benefits that cooperation between renowned distributors can generate for customers in the retail sector: The latest example is a new cooperation on the joint procurement of private labels in France with the renowned buying group Francap, who serves 10 local retailers, representing over 2,200 points of sale, including the French operations of EMD's Belgian partner Colruyt.
Nomination period for the Broermann Medical Innovation Award started17.1.2025 11:35:33 CET | Pressmeddelande
Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields
LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships14.1.2025 13:05:41 CET | Press Release
Andernach – LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company, is proud to announces its selection as a Concept Stage winner for two projects in the #PatchForwardPrize, a $50 million challenge by the Biomedical Advanced Research and Development Authority (BARDA) to advance microneedle patch-based RNA vaccine technologies. The Patch Forward Prize, part of the Project NextGen initiative led by BARDA, aims to accelerate next-generation vaccine technologies. By fostering partnerships between vaccine developers and delivery platform innovators, the competition drives progress from concept to clinical stages, paving the way for transformative advancements in global health. Each of the prizes announced today represents an award of US$ 2 million, that will be shared between LTS and its partners. The awarded projects bring together LTS’s proprietary dissolvable Microneedle Array Patch (MAP) technology with mRNA vaccines from two partners, BioNet, a biotech man
FEV develops AI-supported driver monitoring system CogniSafe9.1.2025 11:00:00 CET | Pressmeddelande
Aachen – FEV, a leading global innovation driver for the mobility of tomorrow, presents CogniSafe, a state-of-the-art Driver Monitoring System (DMS) that significantly increases road safety. The system uses advanced technologies such as deep learning and computer vision to monitor driver conditions such as distraction, fatigue and inattention in real time and under even the most challenging conditions.
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.
Besök vårt pressrum